Zygmont Chester Stanley III 4
4 · REVELATION BIOSCIENCES, INC. · Filed Feb 13, 2025
Insider Transaction Report
Form 4
Zygmont Chester Stanley III
Chief Financial Officer
Transactions
- Award
Common Stock
[F1][F2]2025-02-11$3.87/sh+15,048$58,236→ 15,076 total(indirect: By Trust)
Holdings
- 28(indirect: By Trust)
Common Stock
[F2] - 13(indirect: By LLC)
Common Stock
[F3]
Footnotes (3)
- [F1]Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant.
- [F2]Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
- [F3]Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.
Signature
/s/ J.P. Galda, as attorney-in-fact for Chester S Zygmont III|2025-02-13